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Abstract
Reactive species are products of normal cellular metabolism and may be deleterious or
beneficial. At low/moderate concentrations, reactive species are involved in physiological
roles including cell signalling, defense against infectious agents and mitogenic responses.
However, unbalanced defense mechanism of antioxidants, overproduction of reactive
species or incorporation of free radicals into the living system from the environment may
result in oxidative stress, a deleterious process that can lead to damage of important cell
structures, including lipids and membranes, proteins and nucleic acids. The role of oxida‐
tive stress as a contributing factor in the pathophysiology of various diseases is increas‐
ingly being recognized, and augmenting the oxidative defense capacity of the cell
through the intake of antioxidants as a way of preventing free radical-mediated cellular
injuries is becoming a popular strategy. Much attention is being focused on the health
beneficial role of phenolic phytochemicals derived from plants. They are considered to
play an important role as physiologically functional foods and for the prevention of clini‐
cal conditions related to oxidative stress, even though their modes of action may still not
be fully understood. Rooibos (Aspalathus linearis) is a popular South African tisane en‐
joyed for its taste and aroma. Rooibos has been made in the Cederberg mountain region
of South Africa for generations and has been used medicinally for alleviation of allergies,
asthma, infantile colic and skin problems. The potential antioxidative, immune-modulat‐
ing, chemopreventive and chemotherapeutic actions of rooibos have been reported in
several studies. This review provides a comprehensive data on the current knowledge of
the biological and chemotherapeutic activity of rooibos and its major flavonoids. Most re‐
cent in vitro and in vivo (animal and human) studies were conducted with special atten‐
tion paid to clinical conditions in which oxidative stress has been implicated. The
conclusion described directions for future rooibos research to establish its activity and
utility as a human chemopreventive and therapeutic agent.
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1. Introduction
Oxidative stress results when there is a disturbance in normal cellular and molecular function
as a result of an imbalance between the production of various oxidizing chemical species (pro-
oxidants) and natural antioxidant ability of cells in favour of the former. Pro-oxidants are made
up primarily of free radicals, which are chemical species (molecule, ion or atom) that contains
an unpaired or an odd electron in their outer orbit. As a result of the presence of unpaired
electrons, free radicals are usually very reactive and highly unstable [1,2]. Free radicals target
macromolecules in their proximity for their electrons, thereby oxidizing them and generating
other free radicals. If the macromolecules targeted are important parts of the cellular structure
such as nucleic acids, proteins and lipids, considerable oxidative injury can occur [3]. Free
radicals can be derived from four elements, including oxygen, nitrogen, sulphur and chlorine,
thereby creating reactive oxygen species (ROS), reactive nitrogen species (RNS), reactive
sulphur species (RSS) and reactive chlorine species (RCS). The ROS and RNS are the two main
families of relevant pro-oxidants in biology and medicine. Examples of reactive oxygen species
are superoxide (O2⋅−), hydroxyl radical (OH⋅), singlet oxygen (1O2⋅) and peroxyl radical
(ROO⋅), while examples of reactive nitrogen species include nitric oxide (NO) and nitrogen
dioxide (NO2). Apart from the reactive-free radical species, there are also non-radical reactive
species which, though do not contain unpaired electrons, are either oxidizing agents or easily
converted to free radicals. Examples are hydrogen peroxide (H2O2), organic peroxides such as
lipid hydroperoxides (ROOH), hypochlorous acid (HOCl) and peroxynitrite (ONOO⋅) [4–6].
ROS and RNS often act together to create a state of oxidative stress, as a result of either
depletion of cellular antioxidant defense molecules or overproduction of the reactive species.
2. Generation and interactions of reactive oxygen species
Reactive oxygen species can be generated from many sources, which can be either endogenous
or exogenous. Table 1 shows some major endogenous and exogenous sources of reactive
species.
Endogenous sources Exogenous sources
Mitochondrial electron transport chain Radiation (UV light, X-ray and γ-radiation)
Neutrophils and macrophages during inflammation Environmental pollutants and toxins
Xanthine oxidoreductase, NADPH oxidase Cigarette smoke, excessive alcohol, high-calorie diet
Microsomal oxidation in endoplasmic reticulum Heavy metals
Myeloperoxidase (Phagocytes) Infectious agent
Lipoxygenase, cyclooxygenases, prostaglandin synthase Strenuous exercise
Table 1. Endogenous and exogenous sources of reactive species
Basic Principles and Clinical Significance of Oxidative Stress172
Most ROS are generated via endogenous sources as by-products of normal physiological and
metabolic reactions such as energy generation through the mitochondrial electron transport
chain reaction and protein assemblage by the endoplasmic reticulum [5,7]. The superoxide
radical (O2⋅−) is considered as the primary ROS and it can further interact with other molecules
either directly or prevalently through enzyme- or metal-catalysed processes to generate
secondary ROS [5,8]. The superoxide anion is formed mostly within the mitochondria of a cell
during the electron transport chain reaction. Impairment of the electron transport mechanism
because of damage to mitochondria either during pathophysiological conditions or during
mitochondrial dysfunction results in ROS formation. The electron transport chain is made up
of five multienzyme complexes, which are responsible for ATP generation and maintenance
of mitochondrial membrane potential. The major site of ROS production is assumed to be
complexes I and III [9]; however, ROS can also be generated by other electron complexes, as
well as by other mitochondrial enzymes [10]. During energy transduction, there is a premature
leakage of electrons to molecular oxygen at complexes I and III forming superoxide anion
radical [5,6,11]. Xanthine oxidase is another source of superoxide radical. The enzyme catalyses
a one-electron as well as a two-electron reduction of oxygen to form O2⋅− or H2O2, with itself
being converted to uric acid [12]. Cyclooxygenase, lipoxygenase and cytochrome P450 are
other enzymes that have been proposed to generate ROS. The primary function of these
enzyme systems is not to generate ROS; however, as is the case with the mitochondria, a
dysfunction of these systems in diseases or environmental toxicity generates ROS as a by-
product. The superoxide anion radical produced as a result of a one-electron reduction of
molecular oxygen in the mitochondria is a relatively stable intermediate and its dismutation
by the enzyme manganese superoxide dismutase (MnSOD) will result in the formation of
H2O2 [13]. Protein assemblage by the endoplasmic reticulum, mediated by the enzyme protein
disulphide isomerase and oxidoreductin 1, as well as fatty acid degradation by peroxisomes,
also accounts for O2⋅−, which is dismutated to H2O2 by copper/zinc superoxide dismutase (Cu/
ZnSOD) [14]. The H2O2 produced is a non-radical molecule and it is normally neutralized by
H2O2-removing enzymes, catalase and the glutaredoxin enzyme system (consisting of gluta‐
thione peroxidase, glutathione reductase and glutathione (GSH)) to water and molecular
oxygen [15]. Glutathione peroxidase uses reduced GSH as a substrate and it is converted to
the oxidized form (GSSG). Reduced glutathione is regenerated in a reaction catalysed by
glutathione reductase with subsequent oxidation of NADPH. However, during a period of
iron overload (e.g. conditions of haemochromatosis, haemolytic anaemia and haemodialysis),
in the presence of high amounts of H2O2, heavy metals such as iron (Fe) or copper (Cu) are
freed from iron-containing molecules and there is a subsequent interaction of O2⋅− and H2O2
in a Haber–Weiss reaction or Fe2+ (Cu2+)-driven cleavage of H2O2 in a Fenton reaction to
generate the highly reactive hydroxyl radical (⋅OH) as shown in Figure 1 [12,13,16]. The ⋅OH
radical is highly reactive because of its very short half-life (<1 ns); thus, in vivo, it can react with
macromolecules such as lipids, proteins and nucleic acids in the vicinity of its site of formation,
resulting in oxidative damage to these important cellular components [16]. Other oxygen-
derived free radicals that can be formed in vivo are the peroxyl radicals (ROO⋅) (Figure 1) which
are involved in DNA damage and protein backbone modification and have also been found
to synergistically enhance the induction of DNA damage by superoxide [7].
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Reactive nitrogen species are nitrogen-centred free radicals and include the nitric oxide radical
(NO⋅), nitrosonium cation (⋅NO2), nitroxyl anion (NO−), nitrous oxide radical (NO2⋅) and
peroxynitrite (ONOO−). The NO⋅ radical is the precursor of other RNS and is produced in
higher organisms by the oxidation of one of the terminal guanido-nitrogen atoms of Larginine
in a reaction catalysed by nitric oxide synthase (NOS) [17,18]. The NOS family includes
endothelial NOS (eNOS) and neuronal NOS (nNOS), both of which are constitutively ex‐
pressed isoforms, as well as the transcriptionally regulated isoform, inducible NOS (iNOS),
which has been shown to play an important role in host defense [19–21]. Overproduction of
the RNS above the ability of the cell to neutralize them is known as nitrosative stress and may
lead to nitrosylation reactions that can alter the structure of proteins and so inhibit their normal
function [7]. Oxidative burst during inflammatory processes triggers the formation of both
superoxide and nitric oxide radical from immune cells and they react together to produce the
highly reactive peroxynitrite anion radical which is a potent oxidizing agent that can cause
DNA fragmentation [5,7,22]. Other nitrating agents include the nitrosonium cation formed in
a myeloperoxidase-catalysed reaction involving nitrite (NO2−) and hydrogen peroxide [23,24]
and nitroso-peroxocarbonate (ONO-OCO2−) formed via the reaction of CO2 with ONOO−
[25,26]. A recent study has also shown that lipid peroxyl radicals are able to promote tyrosine
nitration by inducing tyrosine oxidation and also by reacting with NO2⋅ to produce nitrosoni‐
um cation (⋅NO2) [27].
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Figure 1. Sources and generation of different reactive oxygen species. CAT, catalase; GPx, glutathione peroxidase; GR,
glutathione reductase; SOD, superoxide dismutase; RH, lipid membrane; R., alkyl radical
Hypochlorous acid (HOCl) is a non-radical reactive chloride species involved in oxidation and
chlorination reactions. It is usually generated via a myeloperoxidase-catalysed reaction
involving H+, chloride ion and H2O2 by the activated neutrophils [28,29]. Evidence has shown
that HOCl can oxidize thiols and other biological molecules, and chlorinate amines, choles‐
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terol, unsaturated lipids, as well as DNA [28,30]. Although sulphur is considered a component
of cellular antioxidant systems, emerging facts are indicating that reactive sulphur species
(RSS) with similar stressor properties to ROS are generated under condition of oxidative stress
when primary stressors react with cellular components. These reactive sulphur species are
involved in protein activity modulation via thiolation reactions. An important example of an
RSS implicated in physiological process is the thiyl radical (RS.) formed from a one-electron
oxidation of a thiol group as an intermediate to the production of a disulphide, or via the
reaction of sulphydryl groups with ROS such as superoxide radical [31,32]. Thiyl radicals
participate in a series of radical chain reactions that generate other highly reactive sulphur-
centred radicals. For example, a thiyl radical reacts with a thiolate to form the disulphide
radical anion (RSSR.−) and with molecular oxygen to form the thiyl peroxyl radical (RSOO.).
Furthermore, disulphide radical anions interact with molecular oxygen to generate the
disulphide (RSSR) and the superoxide radical [31]. These reactions underline the close
relationship between RSS and ROS.
3. Physiological importance of reactive oxygen species
Reactive oxygen and nitrogen species have generally been considered as being highly reactive
and cytotoxic molecules; however, accumulating evidence has shown that besides their
deleterious effects, ROS participates in physiological processes in a well-controlled manner.
Physiological sources of ROS in the cell are many, but in a number of cells, ROS generated by
the NADPH oxidase enzyme are those implicated in important physiological responses, such
as defense against environmental pathogens or in cell signalling [33]. Reactive oxygen and
nitrogen species are able to influence physiological processes because of their ability to modify
the activity of key protein molecules containing domains sensitive to redox conditions.
Reversible oxidation of the target domain results in the initiation of coupled events, such as
the modification of the activity of downstream enzymes and/or transcription factors. Recent
evidence has shown that at moderate concentrations, nitric oxide (NO), superoxide anion and
related reactive species play an important role as regulatory mediators in cell-signalling
processes and that many of the ROS-mediated responses actually protect the cells against
oxidative stress and re-establish redox balance [4].
Accumulating evidence suggests that oxidants may be important regulators of the cellular
response under hypoxic conditions (oxygen concentrations between 1% and 5%). Although
the molecular basis for this is still obscure, nonetheless, there are suggestions that the release
of ROS under these conditions functions as an important physiological regulator of hypoxia-
inducible factor 1α (HIF-1α), which, under low oxygen conditions, respond to a rise in ROS
and then feedback and inhibit the production of ROS levels [10,34–36]. Other HIF-1α activities
include the transcriptional regulation of metabolic enzymes such as lactate dehydrogenase A
and pyruvate dehydrogenase kinase 1, which control the flow of carbon substrates into the
mitochondria [37,38]. Other studies have also shown that HIF-1α regulates the expression of
certain cytochrome components directly and also regulates specific microRNAs that in turn
regulate the expression of components of the electron transport chain [10,39,40].
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ROS mediate inflammatory responses in a number of ways. In an inflammatory environment,
activated neutrophils and macrophages produce large quantities of superoxide radicals and
other ROS via the phagocytic isoform of NADPH oxidase for the destruction of intracellular
microbes [5,41]. Recent evidence has shown that mitochondrial ROS also contribute to the
phagocytic response of the innate immune system as a result of the activation of a subset of
Toll-like receptors (TLR1, TLR2 and TLR4) [42]. Mitochondrial ROS (mROS) have also been
suggested to be involved in the activation of the inflammasome, thus acting as important
signalling molecules to regulate inflammatory responses. Specifically, mROS have been
implicated in the activation of NLRP3 (NOD-like receptor, pyrin domain-containing 3)
receptor which senses a wide range of damage signals, including environmental irritants,
microorganisms, as well as endogenous danger signals such as ATP and uric acid. When
activated, NLRP3 forms a high-molecular-weight intracellular complex with a number of other
protein partners to regulate the maturation and secretion of pro-inflammatory cytokines such
as IL-1β [10,43–45].
Another physiological role of ROS is the regulation of vascular tone by cGMP. Soluble
guanylate cyclase (sGC) is a heterodimeric protein which catalyses the formation of cGMP.
Soluble guanylate cyclase can be activated by both NO⋅ and H2O2, with NO⋅ activating sGC
by binding to its Fe2+-haem groups resulting in a conformational change at Fe2+ that activates
the enzyme. The cGMP formed is used as an intracellular amplifier and a second messenger
to modulate the function of protein kinases, ion channels and other physiologically important
targets, including smooth muscle tone regulation and platelet adhesion inhibition [5]. Reactive
oxygen and nitrogen species have been implicated in the regulation of autophagy and
apoptosis. Mitochondria-generated ROS regulate autophagy by the direct regulation of Atg4
(autophagy-related gene 4) activity [46,47]. ROS also played an important role in the release
of cytochrome c and other pro-apoptotic proteins, which can trigger caspase activation and
apoptosis. Therefore, small molecules like ROS can affect the complex networks of proteins
mediating the induction and execution of cell death [13].
4. Consequences of oxidative stress
Oxidative attack by ROS is manifested as damage to nucleic acid bases, lipids and proteins,
which can severely compromise cell health and viability or induce a variety of cellular
responses through the generation of secondary reactive species, ultimately leading to cell death
by necrosis or apoptosis [48]. Macromolecular damage via oxidative and/or nitrosative stress,
if unchecked, can theoretically contribute to disease development, and an increasing amount
of evidence suggests that oxidative and/or nitrosative stress is linked to the pathophysiologic
mechanisms of a myriad of human diseases [3,6,48–50].
4.1. Lipid peroxidation
Lipid peroxidation refers to the oxidative degradation of lipids that occur when ROS attack
lipids and extract a hydrogen atom from a methylene carbon in the side chain, and is one of
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the major outcomes of free radical-mediated injury. The cell membrane is one of the most
susceptible sites to ROS damage because the polyunsaturated fatty acid (PUFA) residues of
phospholipids are very sensitive to oxidation. The process of lipid peroxidation occurs in three
stages: initiation, propagation and termination. Reactive species such as O2⋅−, OH⋅, RCOO⋅ and
ONOO⋅ are all potent initiators of lipid peroxidation. During initiation, the fatty acid contain‐
ing the double-bonded carbon chains is oxidized by a free radical to produce a lipid radical
which stabilizes itself by reacting with oxygen to produce the peroxyl radical, which can then
oxidize a neighbouring fatty acid to become a stable hydroperoxide. The oxidized fatty acid
neighbour becomes a lipid radical, which propagates the oxidation process across the lipid
membrane [7,16]. The lipid hydroperoxides formed may then be converted into conjugated
dienes which are unstable and generate a variety of relatively stable end products, mainly
aldehydic by-products, such as malondialdehyde (MDA) and more reactive α-, β-unsaturated
aldehydes, such as trans-4-hydroxy-2-nonenal (4-HNE) and 2-propenal (acrolein) [48,51–54].
Isoprostanes and neuroprostanes and more recently neurofurans are other products that have
been derived from the endocyclization of lipid hyroperoxyl radicals [55–59], and the evaluation
of these end products has been used as an index to determine the extent of oxidative damage
in cells.
4.2. Oxidative protein damage
Proteins are primarily responsible for most functional processes within cells and are thus
highly abundant in biological systems, making them important targets of ROS attack. The
attack of ROS on the polypeptide backbone is initiated by an ⋅OH-dependent abstraction of
the α-hydrogen atom from an amino acid residue to form a carbon-centred radical. Under
aerobic conditions, the carbon-centred radical readily interacts with molecular oxygen to form
peroxyl radicals, which react with the protonated form of superoxide (HO2⋅) and are converted
to the alkyl peroxides [5,60]. Attack by ROS on proteins may lead to the oxidation of amino
acid residue side chains, as well as oxidation of the protein backbone and formation of protein–
protein cross-linkages. Consequently, protein fragmentation and generation of many protein
oxidation products, which can cause damage to other biomolecules, may occur [53,61,62]. All
amino acids within proteins may be attacked by reactive species (including ROS, RNS and
electrophiles); however, the thiol group of cysteine are the most susceptible. Nevertheless,
generally to a lesser extent than cysteine, sulphur-containing methionine and the aromatic
amino acids tyrosine and tryptophan are also susceptible to oxidation [63].The susceptibility
of the thiol group arises from the unique chemistry of cysteine, which confers on the thiol
group specialized properties including nucleophilicity, high-affinity metal binding and/or
ability to form disulphide bonds. The thiol group of cysteine is reported to be ionizable,
generating a negatively charged thiolate group after deprotonation, boosting its reactivity [64].
The functional roles played by thiol groups are linked to this reactivity. Apart from having
high affinities for metals, thiols may be subjected to alkylation by electrophiles (generated by
xenobiotics), oxidation by reactive oxygen species and nitration by reactive nitrogen species
[64–67]. These not only make the thiols versatile in their biological roles but may also lead to
post-translational modifications that alter functions and subvert normal biology.
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Every level of protein structure, from primary to quaternary (if multimeric proteins), may be
altered when proteins are exposed to oxidative attack by ROS, causing major physical changes
in protein structure [48]. Because most protein damage is irreparable, oxidative changes to the
structure of protein can have a wide range of functional consequences including affecting the
function of receptors, enzymes and transport proteins as well as generating new antigens that
can provoke immune responses [68]. Secondary damage to other biomolecules can also result
in the inactivation of DNA repair enzymes and loss of fidelity of damaged DNA polymerases
in replicating DNA [68,69]. Although oxidized proteins are usually degraded by the proteo‐
somal system and the lysosome–macroautophagy pathway, however, the degradation of
damaged proteins may not be completely efficient, resulting in the formation of functionally
inactive protein aggregates, which accumulate with age in separate compartments within cells
or in the extracellular environment [63,70–72]. It is also possible that the proteolytic systems
responsible for the removal of oxidized proteins may be impaired by oxidative stress itself,
thereby accelerating the accumulation of damaged carbonylated-aggregating proteins [73].
Protein aggregates can be highly cytotoxic [74], and increased levels of carbonylated aggre‐
gates have been observed in patients with age-related disorders such as Parkinson disease,
Alzheimer’s disease and cancer [72].
4.3. Oxidative DNA damage
Reactive oxygen species, especially OH⋅ radical generated during oxidative stress, can react
with and cause modifications in all the components of the DNA molecule (the purine and
pyrimidine bases and deoxyribose sugar backbone), causing damage such as base or sugar
lesions, single-strand breaks, double-strand breaks, abasic site formation and DNA–DNA or
DNA–protein cross-links [3,53,75]. Reports have indicated that reactive oxygen and nitrogen
species alone generate several kinds of single-strand breaks and more than 70 oxidative base
and sugar products in DNA [76,77]. It has been estimated that the frequency of oxidative DNA
damage in human cells is 104 lesions/cell/day [78,79]. Although hydrogen peroxide is less
reactive, it is more readily diffusible and thus more likely to be involved in the formation of
oxidized bases through Fenton and Haber–Weiss reactions [60,80,81]. Oxidative damage not
repaired before DNA replication may cause cell death, DNA mutation, replication errors and
genomic instability [7,82–84]. Reports by Halliwell [85] and Valko et al. [8] indicated that
oxidative DNA damage may be related to an increased risk of cancer development later in life.
DNA can also undergo nitrative damage as a result of attack of reactive nitrogen species (RNS)
on DNA bases to form 8-nitroguanine, a mutagenic DNA lesion that can preferentially lead to
G–T transversions, and its formation has been observed in human samples [86]. Attack on
DNA by aldehydic products of lipid peroxidation such as acrolein and 4-HNE can lead to the
formation of bulky exocyclic adducts, which can promote DNA–DNA and DNA–protein cross-
linking and impair transcription factors binding [87–89].
The most commonly used biomarker of DNA damage is the concentration of the nucleoside,
8-hydroxy-2′-deoxyguanosine (8-OHdG), which has been found to be mutagenic in bacterial
and in mammalian cells [3,50,90,91]. Numerous reports have shown that urinary levels of 8-
OHdG were elevated in humans with various malignancies [92–98] and also in experimental
animal models of tumours [99–103].
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5. Endogenous antioxidant defense system
Under normal circumstances, eukaryotic cells have evolved a defense mechanism to limit free
radicals and the damage caused by them. These include systems based on the presence of
antioxidant molecules, the repair of injured molecules and the removal of damaged molecules.
The antioxidant defense system can be endogenous and/or exogenous. The endogenous
system is made up of a network of antioxidant enzymes including superoxide dismutase
(SOD), catalase (CAT), glutathione peroxidase (GPx) and the glutaredoxin and peroxiredoxin
system as well as low-molecular-weight antioxidant molecules such as glutathione. Superox‐
ide dismutase catalyses the dismutation of superoxide anion, converting it to molecular oxygen
and H2O2. There are three isoforms of the SOD family and they all used a transition metal at
their active site. There is a CuZnSOD form in the cytosol and the intermembrane mitochondrial
compartment [104], a MnSOD in the mitochondrial matrix and another form in the extracellular
compartment (e.g. blood) [105].
Although less reactive than the O2⋅− anion, the H2O2 must still be rapidly removed, and this
can be accomplished by the enzymes CAT and GPx working coordinately. Catalase removes
H2O2 at a high rate but shows low affinity for the peroxide; thus, it should be most useful
during the peak of H2O2 production or accumulation [105]. Evidence has shown that this peak
should occur in vivo since acatalasaemia (i.e. disorder caused by lack of catalase) increases
oxidative stress and induces certain pathologies in humans [106]. Glutathione peroxidase may
be present in the selenium- and non-selenium-dependent forms, and it has been shown that
there are at least five selenium-containing GPxs in humans [107,108] whose activities may be
manipulated by changing dietary selenium levels [109]. The isoforms are the ubiquitously
expressed cytosolic GPx (GPx-1) and phospholipid hydroperoxide GPx (GPx-4), epithelium-
specific gastrointestinal GPx (GPx-2), secreted plasma GPX (GPx-3) and GPx-6 found in the
olfactory epithelium and embryonic tissue [108,110,111]. All the GPx isoforms (GPx 1-4 and
GPx-6) can metabolize H2O2 and soluble fatty acid hydroperoxides; however, only GPx-4 can
metabolize complex phospholipid hydroperoxides [107]. The phospholipid hydroperoxide
GPx-4 also differs from other isoforms in that it is a monomer while others are tetrameric
proteins [109]. Glutathione peroxidases use the reducing power of GSH (and other thiols, such
as thioredoxin) to decompose H2O2, and it is the sulphydryl moiety of the cysteine residue that
supplies the reducing equivalent for GPx activity. Two molecules of GSH are oxidized for
every one molecule of H2O2 decomposed, resulting in the formation of GSSG, which can be re-
reduced back to two molecules of GSH by glutathione reductase.
Various low-molecular-weight endogenous non-enzymatic antioxidants are found in animal
and human tissues. These are usually depleted when they react with ROS, but are actually
recycled back to the antioxidant form due to reduction by other molecules. Because of their low
molecular weight, they are able to eliminate ROS at sites that much larger enzymes cannot access
[105]. Reduced glutathione (GSH), thioredoxin and ascorbate are the main low-molecular-
weight  hydrophilic  non-enzymatic  antioxidant  molecules  in  the  cell.  Glutathione  (L-γ-
glutamyl-L-cysteinylglycine) is the predominant intracellular non-protein thiol in eukaryotic
cells. It possesses strong antioxidative properties and consequently plays a crucial role in
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intracellular protection against compounds such as ROS and other free radicals [112–114]. It
functions as a nucleophile to form conjugates with many xenobiotics and/or their metabolites
and can also serve as a reductant in the metabolism of hydrogen peroxides and other organic
hydroperoxides [112,113,115–118]. During interaction with free radicals, the –SH group of GSH
becomes oxidized, leading to the formation of corresponding disulphide compound (GSSG).
Thus, a depletion of GSH is usually associated with an increase in GSSG concentration, and the
ratio between reduced and oxidized forms of GSH serves as an important indicator of the redox
environment [119–121]. The thioredoxin system is another major intracellular antioxidant
system and comprises thioredoxin (Trx), thioredoxin reductase (TrxR) and NADPH. It is an
oxidoreductase with a redox-active disulphide/dithiol at the active site [105,122]. Thioredoxin
is cytoprotective against oxidative stress either directly by quenching singlet oxygen and
scavenging hydroxyl radical or indirectly by reducing oxidized ROS-targeted proteins in
cooperation with peroxiredoxin/thioredoxin-dependent peroxidases [123,124].
6. Exogenous antioxidant defenses: diet-derived compounds
Endogenous antioxidant defense system may not be sufficient when the formation of ROS and
other free radicals is excessive, especially during pathophysiological conditions. Therefore,
additional protective mechanism via exogenous/dietary antioxidants may be required. Well-
known diet-derived antioxidants are vitamins C (ascorbate), E and A, as well as carotenoids.
Next to glutathione, ascorbate is the other most abundant reduced non-enzymatic antioxi‐
dant in cells. It is endogenously synthesized and maintained at high levels in tissues (about 1
mM in rats), but in primates (including human), guinea pigs, fruit-eating bats and many bird
species, it is obtained through diet [125]. Ascorbate can scavenge ROS and other free radicals
by readily donating an electron to potentially damaging radicals such as hydroxyl (OH⋅), alkoxyl
(RO⋅), peroxyl (LOO⋅), thiol radical (GS⋅) and tocopheroxyl radicals (TO⋅) becoming oxidized
to the ascorbate radical (Asc⋅‾) during the process [126,127]. Ascorbate is regenerated from the
Asc⋅‾ by the action of (i) NADH- and NADPH-dependent dehydroascorbate reductase [128–
130], (ii) GSH-dependent dehydroascorbate reductase [131] or (iii) pH-dependent disproportio‐
nation reaction, which results in the formation of ascorbate and dehydroascorbate [132,133].
Reports have shown that GSH and ascorbate interact cooperatively in vivo to cope with ROS
and that ascorbate serves as a co-antioxidant with vitamin E in vivo to protect LDL from detectable
oxidative damage induced by aqueous peroxyl radicals [134].
Vitamin E and carotenoids are the most important antioxidants in the lipophilic environment
of the cell. There are eight known isoforms of the vitamin E family, comprising α-, β-, γ- and
δ-tocopherol and the corresponding tocotrienols [135–137]. Because of the presence of an –OH
group on the chromanol ring of vitamin E, it is able to function as an antioxidant and reduces
lipid peroxyl groups to hydroperoxides, thus terminating the propagation of lipid peroxida‐
tion [105,138]. Empirical evidence for carotenoids being important antioxidants in vivo is weak
[105,139]. Recent reports on birds showed that carotenoids have a very low contribution to
protection against oxidative damage under stressful conditions [140–144]. Many human trials
where carotenoids and other dietary antioxidants (vitamin C and E) were administered singly
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or together did not show any positive effect and even contributed to mortality among study
subjects [145–148].
In addition to the vitamins and carotenoids, plant-derived phenolics are other exogenous
source of antioxidant defense compounds. The intake of exogenous antioxidants from teas,
fruits, vegetables and spices is of nutritional interest since it has been associated with the
modulation of oxidative stress and cellular damage, as well as with the provision of substantial
health benefits. Diet has been known as a risk factor for chronic diseases for many years, and
the upsurge in cases of chronic diseases worldwide in the past decades has been attributed in
part to the change from traditional, largely plant-based diet to the high-fat, energy-dense diets
with substantial content of animal fat [149]. In addition, the Mediterranean diet characterized
by frequent consumption of fruits, vegetables, legumes, cereals and fish and low in meat and
cheese is positively associated with a reduced risk of most chronic diseases including cardio‐
vascular diseases (CVDs), diabetes and cancer [150]. Fruits, vegetables, spices and teas are
excellent sources of fibre, vitamins and minerals, but they also contain components such as
polyphenols, terpenes, alkaloids and phenolics, which may provide substantial health benefits
beyond basic nutritional functions [151]. Disease prevention using whole plant extracts, or
isolated compounds from plant (phytochemicals), is gaining more scientific attention world‐
wide, because it is a cost-effective alternative to orthodox treatment, and the phytochemicals
are presumed from anecdotal evidence to be safe, with low toxicity and general acceptance
[152,153]. Whole plant extracts as well as isolated molecules have been shown to possess
antioxidant, anti-inflammatory, anticancer and tumour inhibitory effects. The health-promot‐
ing effects of these plants are suggested to be due to the polyphenolic antioxidant molecules
that they contain. Plants often contain different polyphenolic phytochemicals, and it is the
general assumption that the observed health effects of these plants may be due to the additive
and/or synergistic effects of the complex mixture of these phytochemicals rather than the effect
of a single molecule [154–156].
7. Plant phenolics and polyphenols
With an excess of 8000 phenolic structures being reported, plant phenolics are one of the most
widely dispersed groups of phytochemicals in the plant kingdom. Structurally, they are
characterized by having at least one aromatic ring with one or more hydroxyl groups and can
range from low-molecular-weight, simple aromatic-ring compounds to large and complex
tannins and derived polyphenols [157,158]. Phenolics are secondary metabolites produced
during diverse physiological processes in the plants, such as growth, lignification, pigmenta‐
tion, pollination and defense against pathogens, predators and environmental stress [159].
According to Crozier et al. [157], plant phenolics occurring naturally in healthy plant tissue
can be classified into (i) flavonoids and (ii) non-flavonoids. The major non-flavonoids of dietary
significance include phenolic acids, phenolic alcohols, stilbenes and the lignans. Flavonoids
are widely distributed in food and beverages of plant origin, including teas, fruits, vegetables,
spices, cocoa and wine that form part of human diet. In plants, they play key roles in growth
and development [160], plant–insect interactions [161] and protection against harmful
Rooibos (Aspalathus linearis) and its Major Flavonoids — Potential Against Oxidative Stress-Induced Conditions
http://dx.doi.org/10.5772/61614
181
radiation by absorbing ultraviolet B (UVB) and scavenging ROS generated by UVB irradiation
[162,163]. Flavonoids are known to provide health-promoting effects in humans who consume
them. Reports have shown that flavonoids possess many useful health properties, including
anti-inflammatory, oestrogenic, enzyme system modulation, antimicrobial, vascular and
antitumour activity; however, the antioxidant activity is the most studied one that is attributed
to flavonoids and has been found to be responsible for other biological activities in which the
prevention of oxidative stress is beneficial [164–166]. Flavonoids also possess anticancer
activity, which has been shown to go beyond the antioxidant, free radical-scavenging activity,
but may involve mechanisms such as regulation of gene expression in cell proliferation,
oncogenes and tumour suppressor genes, induction of cell cycle arrest and apoptosis, modu‐
lation of detoxification enzymes activity, stimulation of immune system and regulation of
hormone metabolism [165]. The main subclasses of flavonoids are flavones, flavonols,
flavanols, anthocyanins, isoflavones, flavanones, chalcones and dihydrochalcones [157,164–
166]. Other classes include the coumarins, aurones, dihydroflavonols and flavan-3,4-diols.
8. Rooibos (Aspalathus linearis)
8.1. History, distribution of the species and morphology
Rooibos, Aspalathus linearis (Brum f) Dahlg. (Family Fabaceae; tribe Crotolarieae), is a hardy
shrub that grows between 1.5 and 2 m in height with bright green, needle-shaped leaves and
small, yellow flowers [167]. After harvesting, the needle-like leaves and stems can be either
bruised and fermented prior to drying or dried immediately [168]. The unfermented product
remains green in colour and is referred to as green rooibos. During fermentation, the colour
changes from green to red as a result of the oxidation of the constituent polyphenols and the
final product is often referred to as red tea or red bush tea. The genus Aspalathus comprises
about 278 species and is endemic to South Africa, showing a high degree of polymorphism in
terms of morphology, geographical distribution, ecology and phenolic constituents [169].
Rooibos has been consumed by locals for over 300 years, but it was not known outside South
Africa until 1904 when Benjamin Ginsberg, a Russian immigrant to South Africa, recognized
its potential and started trading with rooibos that he bought from the Khoi descendants and
became the first exporter of rooibos. In the 1930s, Dr P.F. Le Fras Nortier, a local doctor and
amateur botanist, realized the commercial potential of rooibos and initiated its cultivation in
plantations by local farmers (http://www.sarooibos.co.za/content/view/31/79; retrieved on
08/10/2010). By 1999/2000, rooibos production was between 4500 and 6000 metric tonnes with
the domestic market absorbing 70–75% of the annual production. Today, rooibos cultivation
has reached a large scale of more than 12,000 metric tonnes, serving both local and increasing
international market demand [170].
8.2. Phytochemical composition
The herbal beverage made from rooibos is naturally caffeine-free [171,172] and low in tannin
when compared to Camellia sinensis teas [173]. The leaf tannin content of rooibos is reported to
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be about 3.2–4.4% [174,175]. Rooibos is unique in its monomeric flavonoid composition,
containing two unique compounds, namely aspalathin and aspalalinin. Aspalathin is a C–C-
linked dihydrochalcone glucoside [176,177] and aspalalinin is a cyclic dihydrochalcone [178],
and both are only isolated from rooibos. Rooibos is also one of the only three known sources
of nothofagin, a 3-dehydroxydihydrochalcone glucoside [179,180]. The other known sources
of nothofagin are the heartwood of Nothofagus fusca [181] and the bark of a Chinese medicinal
plant, Schoepfia chinensis [182]. Other flavonoids in rooibos include the C–C-linked β-D-
glucopyranosides such as flavones orientin and iso-orientin [183] as well as vitexin and
isovitexin, both flavone analogues of nothofagin [177]. The flavanones, dihydro-orientin and
dihydroiso-orientin [184], as well as hemiphlorin [178] have also been isolated from rooibos.
Other flavones isolated from rooibos include chrysoeriol, luteolin and luteolin-7-o-glucoside,
while the flavonols quercetin, quercetin-3-orobinoside, hyperoside, isoquercitrin and rutin are
also present [177,178,184–187]. The presence of phenolic acids, lignans and the coumarin,
esculentin [177,178,187], as well as monomeric flavan-3-ol, (+)-catechin and oligomeric
flavan-3-ol, procyanidin B3 and bis-fisetinidol-(4β,6:4β,8)-cathechin [187,188], has also been
detected in rooibos. Figure 2 shows the major flavonoids that have been identified from
rooibos.
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Figure 2. Some major flavonoids identified in rooibos (Glc = C-β-D-glucosyl group)
As a result of fermentation during the processing of rooibos, the content of polyphenols in
rooibos is reduced. Studies have found a higher percentage of total polyphenols, flavonoids
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and non-flavonoids in unfermented/green rooibos compared to fermented/red rooibos [189–
191]. These differences may be attributed to (i) the enzymatic and chemical modifications that
occur during fermentation and (ii) the processing methods used [179,190]. During fermenta‐
tion, aspalathin present in unfermented rooibos is extensively oxidized to dihydroiso-orientin.
Nothofagin, iso-orientin, isovitexin and vitexin are degraded as well, but to a lesser extent
[179,187,192,193]. In vitro studies revealed that fermentation and processing also affect the
antioxidant activities of rooibos, with results showing that antioxidant activity (measured by
different free radical-scavenging assays) decreases with fermentation [190,194–196], an effect
attributed to a decreased total polyphenol content with fermentation.
9. Biological activities and potential of rooibos in oxidative stress-induced
conditions
The attractiveness and use of naturally occurring compounds including those derived from
fruits, vegetables, teas, various herbs and spices as potential chemopreventive and chemo‐
therapeutic agents are gaining worldwide appeal. Evidence abounds that rooibos and/or its
flavonoids hold great potential not only in the prevention but also in therapy of a wide variety
of disease conditions. Since the first report on the biological activity of rooibos, an enormous
body of work has revealed that rooibos extracts possess antioxidant, antimutagenic, anti-
inflammatory, anti-diabetic, hepatoprotective, antimicrobial and, above all, cancer-preventive
properties. The following sections will therefore take a detailed look at the various biological
and health-promoting effects that have been shown for rooibos.
9.1. Antioxidant and lipid peroxidation inhibition activities
Although the controlled production of ROS has important physiological roles especially in
energy production, phagocytosis, regulation of cell growth and cellular signalling, a high ROS
production not counterbalanced by cellular antioxidant defense may result in oxidative stress.
As previously mentioned, oxidative stress has been implicated in the pathogenesis of many
disease conditions such as cancer, cardiovascular diseases, atherosclerosis, hypertension,
ischaemia/reperfusion injury, diabetes mellitus, neurodegenerative disorders (Alzheimer’s
and Parkinson’s disease), rheumatoid arthritis and ageing. Rooibos is a potent source of unique
and beneficial phytochemicals, which are thought to contribute to its health benefits. Several
studies have confirmed that rooibos showed antioxidant and lipid peroxidation inhibition
activities both in vitro and in vivo. Extracts of fermented and unfermented rooibos as well as
rooibos flavonoids showed in vitro antioxidant activity by scavenging free radicals [190,194–
199]. Aqueous extracts of fermented rooibos showed in vitro inhibition of lipid peroxidation
in cell membranes using rabbit erythrocyte membrane, rat liver microsome and rat liver
homogenates [196,200], while methanolic extracts of fermented and unfermented rooibos
inhibited microsomal lipid peroxidation [201]. Rooibos was also shown to scavenge alkyl
peroxyl radicals formed during lipid peroxidation [202]. Aqueous and methanolic extracts of
rooibos inhibited peroxyl radical-induced DNA strand scission in a dose-dependent manner,
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with the aqueous extract being less effective compared with the methanolic extract [203].
Treatment with fermented rooibos increased the viability of Chinese hamster fibroblast (V79-4)
cells following H2O2-induced oxidative stress by increasing the activity of antioxidant enzymes
superoxide dismutase (SOD) and catalase (CAT) [204].
The antioxidant effects shown by rooibos in vitro has been confirmed in many experimental
animal model studies. Aqueous rooibos extract administration suppressed age-related
accumulation of lipid peroxides in several regions of the rat brain [205]. Gastric intubation of
luteolin (a flavonoid found in rooibos, at 10-µmol/kg body weight) given 2 hours prior to γ-
ray irradiation suppressed lipid peroxidation in mice bone marrow and spleen [206]. In a study
in vitamin E-deficient rats, dietary supplementation of a freeze-dried hot water extract of
rooibos decreased the level of lipid peroxidation in the liver, lung, small intestine and stomach
of the animals, although the changes were not significant [207].
In the presence of reactive species, GSH is rapidly oxidized to GSSG and in its turn exported
from cells. Intracellular levels of GSH, GSSG or the ratio of GSH:GSSG serve as good indicators
of oxidative stress. The ability of rooibos extracts to inhibit lipid peroxidation and modulate
antioxidant status in different organs and/or tissues has been widely reported. In 2003,
Marnewick et al. [208] reported on the effect that chronic feeding of a 2% (w/v) aqueous extracts
of both fermented and green rooibos had on the modulation of oxidative stress in male Fischer
rats. Consumption of the fermented and green rooibos extract for 10 weeks did not have any
effect on the antioxidant capacity (measured as ORAC) of the liver; however, both extracts
significantly improved the glutathione (GSH) redox status of the liver by reducing the level of
oxidized glutathione (GSSG) and thus increasing the GSH:GSSG ratio significantly. Simulta‐
neously, the rooibos extracts also significantly enhanced the activities of the important hepatic
phase II drug-metabolizing enzymes, glutathione S-transferase alpha and UDP-glucoronosyl
transferase.
Using different models of induced oxidative stress, the effect of rooibos extracts supplemen‐
tation has been reported widely. Fermented rooibos extract given for 10 weeks increased the
antioxidant status of the CCl4-treated rats by increasing α-tocopherol and reducing the liver
concentrations of coenzyme Q while inhibiting the formation of malondialdehyde [209]. A
study by Awoniyi et al. [210] reported that fermented and green rooibos offer a measure of
protection against tert-butyl hydroperoxide (t-BHP)-induced oxidative damage in rat sperm
by increasing the antioxidant defense mechanism and thereby improving sperm motility and
function. The authors concluded that a wide spectrum of polyphenolic compounds present in
rooibos are effective as antioxidants; thus, rooibos could offer a therapeutic effect in the
treatment of infertility. More recent studies in our laboratory have also reported on the ability
of rooibos to inhibit lipid peroxidation and improve the glutathione redox status in the liver
of rats. In one of the studies, male Wistar rats were supplemented with fermented rooibos for
10 weeks, while oxidative stress was induced by intraperitoneal injection of t-BHP in the last
2 weeks. Results from this study showed that rooibos supplementation was able to inhibit lipid
peroxidation by decreasing the elevation in conjugated dienes and malondialdehyde levels
induced by t-BHP. Simultaneously, the fermented rooibos extract also improves the gluta‐
thione redox status by increasing the reduced glutathione (GSH) concentration and invariably
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the GSH/GSSG ratio in the plasma and liver of the rats [211]. In another study, lipopolysac‐
charide (LPS) (Escherichia coli, serotype 0111:B4, 0.5 mg/kg b.w., i.p.) was used as an oxidative
damage inducer in rats pre-fed fermented rooibos for 4 weeks. Results showed that pre-feeding
rooibos inhibited plasma and hepatic formation of malondialdehyde (marker of lipid peroxi‐
dation) and also restored the impairment in glutathione redox status [212]. These studies
showed that rooibos and its constituent polyphenols are effective antioxidants in vivo.
Although the mechanisms by which rooibos offers protection in oxidative stress-induced
conditions are not fully understood, however, we believed that the potential mechanisms by
which this protection is achieved could involve one or more of several different antioxidant
properties exhibited by flavonoids in rooibos. Rooibos polyphenols could be scavenging ROS
directly by binding lipid peroxides or they may act as sacrificial antioxidants to inhibit the
lipid peroxidation cascade. In improving the glutathione redox status, rooibos improved the
antioxidant status of the cell. This effect may result from the ability of flavonoids present in
rooibos to up-regulate the mRNA expression of γ-glutamylcysteine synthetase, the rate-
limiting enzyme in the biosynthesis of glutathione.
9.2. Hepatoprotective effects
Chronic hepatic disease represents one of the foremost health problems worldwide, with liver
cirrhosis and drug-induced liver injury accounting for the ninth leading cause of death in the
western and developing countries [213]. In vitro and in vivo evidence suggests that free radical
damage and oxidative stress contributing to lipid peroxidation is a critical mechanism
implicated in the genesis and progression of different chronic liver diseases. It is a well-known
fact that the available synthetic drug to treat liver disorders might also cause further damage
to the liver [214]. Hence, medicinal plants have become increasingly popular and their use is
widespread.
Hepatoprotective effects of rooibos has been reported in a number of studies. Consumption
of rooibos protected against liver damage by suppressing the observed increase in plasma
activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline
phosphatase and bilirubin, and resulted in a histological regression of steatosis and cirrhosis
in the liver of rats challenged with carbon tetrachloride (1 mL/kg, i.p.) twice a week for 10
weeks [215]. Another study from the same laboratory also reported that rooibos supported the
regeneration of rat liver after intoxication with carbon tetrachloride, and this protective effect
was ascribed to the ability of rooibos to inhibit lipid peroxidation in the liver [216].
In a t-BHP-induced hepatotoxicity model study, fermented rooibos consumption by rats
reversed the elevation in serum aminotransferases and lactate dehydrogenase induced by t-
BHP [211]. Histologically, the severe hepatic degeneration, hepatocyte vacuolation as well as
massive lymphocyte and mononuclear cellular aggregation induced by t-BHP were also
reversed. The hepatoprotective effect of rooibos was confirmed in another study by the same
group when they reported on the amelioration of lipopolysaccharide-induced acute liver
injury by a fermented rooibos extract [212]. Based on the result from these studies, the authors
concluded that the hepatoprotective effects shown by fermented rooibos could be ascribed to
a stabilizing effect of rooibos phenolics on the plasma membrane of hepatocytes, as well as the
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repair of damaged hepatic tissues probably brought about by the stimulation of hepatocellular
protein synthesis and accelerated regeneration of the hepatocytes, thus suggesting that rooibos
may be of benefit in the prophylactic management of oxidant-induced liver injuries.
9.3. Anti-diabetic effects
Diabetes is one of the most common global diseases and affects approximately 200 million
people worldwide [217,218], with the figure forecasted to rise to around 300 million people by
2025 [219]. Long-term effects of diabetes include progressive development of specific comple‐
ments such as retinopathy, nephropathy and neuropathy. People with diabetes are also at risk
for cardiovascular, peripheral vascular and cerebrovascular diseases. All these complications
substantially increase the rates of morbidity and mortality associated with the disease and
reduce the quality of life of the diabetic individuals. A chronic disease characterized by
increased blood sugar, diabetes can result from lack of insulin production and/or resistance to
insulin. Insulin resistance alone does not result in the development of type 2 diabetes, and
reports have shown that there must be progressive dysfunction of pancreatic islets, which
disrupt the secretion of glucagon from the α cells and insulin from β cells, leading to uncon‐
trolled hyperglycaemia, for the disease to develop [220].
Experimental evidence suggests the involvement of overproduction of free radicals in the onset
of diabetes and diabetic complications, with oxidative stress proposed as a pathogenic
mechanism linking insulin resistance with the dysfunction of beta cells and endothelium,
impaired glucose tolerance and overt diabetes. β-Cell dysfunction in the diabetic state may
result from a decrease in β-cell mass, and this has been attributed to oxidative stress-induced
apoptosis [221]. The apoptotic state in the β-cells was reported to be triggered by high glucose
concentration (glucotoxicity), possibly due to increased production of ROS. In addition,
evidence has shown that β-cells have very low expression of antioxidant enzymes, making
them more susceptible to oxidative damage [221–223]. Both pancreatic α- and β-cells play vital
roles in the maintenance of normal glucose homeostasis, and studies has shown that abnormal
glucagon secretion is a hallmark of the diabetic state, suggesting that glucose sensing by the
α-cells is also dysfunctional [224,225]. The effect of oxidative stress on α-cells in the diabetic
state is less clear; however, evidence has shown that uncoupling protein 2 (UCP 2), a mito‐
chondrial proton carrier protein, is highly expressed in pancreatic α-cells [225]. A central role
has been suggested for UCP 2 in ROS-mediated injury in the diabetic state, with several reports
indicating that UCP 2 is negatively correlated with the level of ROS generation by respiring
mitochondria [226]. Some authors have reported that in contrast to β-cells, islet α-cells are
resistant to diabetogenic toxins, an observation the authors adduced to the fact that α-cells
displayed high level of catalase expression and activity [227], suggesting that α-cells may be
more resistant to ROS damage. Biomarkers of oxidative damage including malondialdehyde,
F2-isoprostane, protein carbonyls and advanced glycation end products (AGE) are reported
to be elevated in either the plasma, erythrocytes or liver of streptozotocin (STZ)-induced
diabetic rats [228–231], as well as in the plasma or urine of diabetic patients [232–234], giving
further evidence of ROS contribution to the onset, progression and pathological consequence
of diabetes. In addition, the level of cellular non-enzymatic antioxidants such as vitamin E,
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vitamin C and reduced GSH is depleted in different tissues of experimentally induced diabetes
[235,236] and in diabetic patients [234,237–239]. The modulation of the antioxidant enzymes
network in the diabetic state is another indirect evidence in support of the role of oxidative
stress in diabetes and diabetic complications, an effect which has been reported to be highly
variable, depending on the model of diabetes used and the tissue type assessed [240].
Several polyphenol-rich plants and/or plant extracts have been used for controlling diabetes
[241,242]. Polyphenols may affect glycaemia through different mechanisms, including
inhibition of intestinal glucose absorption, increasing glucose transport and metabolism in
muscle and/or stimulating insulin secretion [217,219,243,244]. A report by Johnston et al. [245]
demonstrated that glucose uptake into cells under sodium-dependent conditions was inhib‐
ited by flavonoid glycosides and non-glycosylated polyphenols in polarized Caco-2 intestinal
cells. Under sodium-free conditions, aglycones and non-glycosylated polyphenols inhibited
glucose uptake, whereas glycosides inhibited the active transport of glucose [246].
Investigation into the anti-diabetic properties of rooibos in streptozotocin-induced diabetic
rats showed that the administration of aqueous and alkaline extracts of rooibos to diabetic rats
did not affect markers of diabetic status such as glucose, glycated haemoglobin and fructosa‐
mine; however, biochemical markers characterizing hepatotoxic effects in plasma, advanced
glycation end products (AGEs) and malondialdehyde in plasma and in different tissues of the
diabetic rats were reduced [247]. Previously, an in vitro study by Kinae et al. [248] reported
that a freeze-dried extract of fermented rooibos suppressed the formation of glycated albumin,
including AGEs in a mixture of D-glucose and human serum albumin. Quercetin, a flavonol
found in rooibos in small concentrations, has been shown to mediate the inhibition of the
facilitated diffusion of glucose transporter 2 (GLUT2) in Chinese hamster ovary cells [249].
The hypoglycaemic and anti-diabetic activity of aspalathin (major polyphenol of rooibos) in
type 2 diabetic model db/db mice was demonstrated for the first time in a study by Kawano
et al. [250]. In the study, purified aspalathin from a fermented rooibos extract increased dose-
dependently and significantly the glucose uptake by L6 myotubes at concentrations of 1-100
µM, irrespective of insulin absence and also increased insulin secretion from cultured RIN-5F
cells at 100 µM. Dietary aspalathin (0.1–0.2%, g/kg diet) suppressed the increase in fasting
blood glucose levels for 5 weeks and improved impaired glucose tolerance at 30, 60, 90 and
120 min in db/db mice. The results from this study presented the first evidence of the beneficial
effects of aspalathin on glucose homeostasis in type 2 diabetes, through the stimulation of
glucose uptake in muscle tissues, and insulin secretion from pancreatic β-cells.
In another study, a fermented aqueous extract and an aspalathin-enriched unfermented extract
of rooibos were reported to lower the elevation in blood glucose observed, in an STZ-induced
hyperglycaemic Wistar rat model [251]. The same study also reported that the elevated blood
glucose observed in a diet-induced model of type 2 diabetes in vervet monkeys was lowered
by a fermented aqueous extract of rooibos.
The hypoglycaemic potential of an aspalathin-enriched green rooibos extract, aspalathin, rutin
and an aspalathin–rutin mixture was investigated by Muller et al. [252] in C2C12 myotubules
and STZ-induced diabetic rats. Results from the study showed that the enriched green rooibos
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extract induced a dose–response increase in glucose uptake on C2C12 myotubules; aspalathin
was effective at 1, 10 and 100 µM while rutin was effective at 100 µM. In STZ-induced diabetic
rats, the aspalathin-enriched rooibos extract and the aspalathin–rutin mixture but not the
single compounds separately reduced blood glucose concentrations, indicating that the
hypoglycaemic effect may be due to synergistic interactions of polyphenols present in rooibos.
Using a similar in vitro approach in C2C12 muscle cells, Mazibuko et al. [253] reported that an
aspalathin-enriched green rooibos extract and an aqueous extract of fermented rooibos
ameliorate palmitate-induced insulin resistance, with both extracts increasing glucose uptake,
mitochondrial activity and ATP production. Further studies from the same group revealed
that fermented rooibos extract has a potential for preventing obesity by inhibiting adipogenesis
in differentiating 3T3-L1 adipocytes [254] and also showed cardioprotective effect in isolated
cardiomyocytes derived from diabetic rats, subjected to experimentally-induced oxidative
stress and ischaemia [255].
Vascular inflammation induced by high glucose is key in the initiation and progression of
arthrosclerosis, a major diabetic complication. In another study investigating the benefit of
rooibos in the treatment of diabetic complications, Ku et al. [256] assess whether aspalathin
and nothofagin can suppress vascular inflammation induced by high glucose in human
umbilical vein endothelial cells (HUVECs) and mice. Results from the study showed that
aspalathin and nothofagin inhibited high glucose-mediated vascular permeability, adhesion
of monocytes towards HUVEC and expression of cell adhesion molecules and suppressed ROS
formation and nuclear factor-кβ (NF-кβ) activation in vitro and in vivo.
Although these studies strongly suggest that rooibos and its polyphenols effect their antidia‐
betic potential through multiple modes of action, some authors have suggested that because
rooibos and/or aspalathin are capable of scavenging intracellular reactive oxygen species
(ROS), the anti-diabetic potential of rooibos may be due to its antioxidative function, which
may be involved in the activation of insulin-stimulated glucose uptake, and hence the
modulation of glucose homeostasis [257].
9.4. Antimutagenic, antitumourigenic and anti-carcinogenic effects
The increasing mortality and morbidity arising from various cancers worldwide have made
the search for an alternative strategy (such as the use of bioactive components from plants) in
the prevention and management of cancers very imperative. Results from studies in recent
decades have shown that bioactive compounds from plants have important roles in the
prevention, and reducing the risks of chronic diseases, including cancer [258,259]. The
beneficial effects shown by these compounds are attributed, among others, to their antioxidant
and free radical-scavenging ability.
Rooibos is a rich and unique source of polyphenols, and the polyphenols present in rooibos
being powerful antioxidants may play important roles in the prevention of cancer by reducing
damage to DNA in the cell, and modulating the promotion of cancer. Several studies have
demonstrated the in vitro antimutagenic properties of both fermented and unfermented
rooibos extracts using various test systems. Fermented aqueous rooibos extract (3.33%, w/v)
significantly suppressed the number of chromosomal aberrations in Chinese hamster ovary
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cells induced by benzo[a]pyrene (BaP) and mitomycin C (MMC) in the presence or absence of
rat liver microsomal enzymes (S9). The clastogen-suppressing effect was obtained when cells
were exposed to rooibos before and/or after mutagen treatment [260]. Aqueous extract of
rooibos (2–10% of extract) suppressed oncogenic transformation of mouse fibroblast cells
subjected to X-ray-induced transformation in a dose-dependent manner [261]. In another
study, the effect of different concentrations of a fermented rooibos extract included in the
culture medium, on growth and changes of growth parameters of cultured chick embryonic
skeletal muscle cells, was investigated. It was discovered that the rooibos extract significantly
inhibited cell proliferation as reflected by decreased DNA, RNA and protein contents in
primary cell cultures of fibroblasts and myoblasts, in a dose-dependent manner [262]. The in
vitro antimutagenic property of rooibos was further investigated by Marnewick et al. [189].
Both fermented and unfermented rooibos extracts (5% and 10%, w/v) were significantly
effective against 2-acetylaminofluorene (2-AAF) and aflatoxin B1 (AFB1)-induced mutagenesis
in the Salmonella typhimurium mutagenicity assay (tester strain TA98 and TA100) in the
presence of metabolic activation with S9. However, poor inhibitory effects against the direct-
acting mutagens, methyl methanesulphonate, cumene hydroperoxide and H2O2 using tester
strain TA102, were observed. Further studies using the same Salmonella assay revealed that
fermented rooibos exhibited a higher antimutagenic activity than unfermented rooibos against
both AFB1 and 2-AAF, although antimutagenic activity of both rooibos extracts was compa‐
rable to that of an extract prepared from Camellia sinensis [263]. Using genetically engineered
V79 Chinese hamster fibroblasts that expressed human CYP1A2, N(O)-acetyltransferase
(hNAT2*4) and sulphotransferase (hSULT1A1*1), Platt et al. [264] showed that rooibos
moderately protects against the genotoxicity of 2-amino-3-methylimidazo(4,5-f)quinoline (IQ)
and the protection shown was comparable to that shown by green and black teas. In another
study, aqueous extracts of unfermented rooibos inhibited cell proliferation of human oeso‐
phageal cancer cells (WHCO5) by affecting energy (ATP) production [265]. The antimutagenic
properties of the most prevalent flavonoids in rooibos (aspalathin and nothofagin) and their
flavone derivatives were investigated by Snijman et al. [266]. The results showed that aspala‐
thin, nothofagin and their structural flavonoid analogues displayed moderate antimutagenic
properties, while luteolin and to some extent chrysoeriol showed activities comparable to those
of the green tea flavonoids, EGCG. In the same study, quercetin and isoquercetin exhibited
antimutagenic, pro-mutagenic and mutagenic effects in the presence or absence of metabolic
activation.
The in vitro antimutagenic potential of rooibos extracts has been substantiated by several
animal model experiments. Intraperitoneal injection of fermented rooibos extract (1 mL of
0.1%, w/v) 6 h prior to MMC treatment reduced the induction of micronucleated reticulocytes
(MNRETs) in peripheral blood of ICR male mice [260]. The ex vivo antimutagenic potential of
fermented and unfermented rooibos was established in a 10-week rooibos feeding study in
male Fischer rats. It was discovered that liver cytosolic fractions from rats consuming fer‐
mented and unfermented rooibos protected against AFB1-induced mutagenesis in the
Salmonella typhimurium assay with tester strain TA100. However, only liver cytosolic fraction
from rats fed the unfermented rooibos showed protection against 2-AAF-induced mutagenesis
in the same assay with tester strain TA98 [267]. In addition, the activation potential of hepatic
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microsomal preparations from rats consuming rooibos was evaluated in the study, with
rooibos reducing the activation of AFB1, but not that of 2-AAF.
The antitumourigenic activity of rooibos was established in a two-stage mouse skin carcino‐
genesis assay. Topical application of ethanol/acetone soluble fractions of fermented and
unfermented rooibos prior to tumour promotion with 12-O-tetradecanoylphorbol-13-acetate
(TPA) on ICR mouse skin initiated with 7,12-dimethylbenz(a)anthracene (DMBA) significantly
reduced the number and size of tumours per mouse, as well as delayed tumour development
[201]. More recently, a study in female SKH-1 hairless mice showed that the topical application
of polyphenol-rich extracts of fermented and unfermented rooibos, prior to ultraviolet B-
induced tumour promotion and after DMBA-initiated skin cancer, reduced the number of
tumours per mouse by 91.39% and 75.37%, respectively, and also the tumour volume by 97.28%
and 90.74%, respectively [268]. Another study related to tumour promotion in mouse skin
showed that the expression of cyclooxygenase-2 (COX2) in ICR mouse skin by TPA was
significantly reduced by a methanolic extract of fermented rooibos (60, 300, 600 µg, topically
applied prior to TPA exposure) [269]. A recent study, which monitored the cancer-modulating
properties of hot water extracts of fermented and unfermented rooibos in a liver carcinogenesis
model against fumonisin B1 (FB1) promotion in male Fischer rat using diethylnitrosamine as
cancer initiator, showed that unfermented rooibos was more protective against FB1-induced
cancer promotion, by significantly reducing the total number and size of pre-neoplastic foci
staining positively for the placental form of γ-glutamyl transferase in the liver, presumably by
arresting their growth [270]. A similar study investigated the protective effect of rooibos
against methylbenzylnitrosamine-induced oesophageal cancer in male Fischer rats and
reported that fermented and unfermented rooibos significantly reduced the number and size
of papillomas, with rats drinking unfermented rooibos failing to develop larger papillomas
[265,271]. Results from these studies suggest that rooibos could be developed as a nutraceutical
for the chemoprevention of liver and oesophageal cancer.
9.5. Anti-inflammatory effects
Inflammation plays an important role in various diseases, such as rheumatoid arthritis,
atherosclerosis and cardiovascular diseases, type 2 diabetes and cancers, which all show a high
prevalence globally. Since ancient times, in various cultures worldwide, inflammatory
disorders and related diseases have been treated with plants or plant-derived formulations,
and the anti-inflammatory activity of several plant extracts and isolated compounds has been
demonstrated scientifically [272]. A possible explanation for these anti-inflammatory effects
of plant extracts may be found in the interplay between oxidative stress and inflammation.
ROS are involved not only in the occurrence of oxidative stress but also in the promotion of
inflammatory processes via activation of transcription factors such as NF-кβ and activator
protein (AP)-1, which induce the production of cytokines like TNF-α [273,274].
Scientific studies reporting on the possible anti-inflammatory effects of rooibos and/or its
flavonoids are sparse. A study in Japan reported that unfermented rooibos extract (1.6%,
w/v) administration as the only source of drinking fluid for 8 weeks reduced inflammation in
dextran sodium sulphate (DSS)-induced colitis rats via an increased antioxidant activity [275].
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There was a significant increase in serum SOD and urine 8-hydroxy-2´deoxyguanosine levels
in rooibos rats compared to the control and the DSS rats. Based on these findings, the authors
concluded that rooibos may prevent DNA damage and inflammation by its antioxidative
activity in vivo. The anti-inflammatory activity of a rooibos tea extract in DMSO (0.5 mg/mL)
and two of its flavonoids (luteolin and quercetin) was investigated, together with that of other
herbal extracts, in a study using a lipopolysaccharide-stimulated macrophage model. The
study results revealed that incubation with a rooibos extract (0.5 mg/mL) significantly reduced
the secretion of the pro-inflammatory cytokine, IL-6, by at least 25% and marginally reduced
the expression of inducible nitric oxide synthase (iNOS). However, the secretion of the anti-
inflammatory cytokine, IL-10, was also reduced [272]. In the same study, rooibos flavonoids
luteolin and quercetin at concentrations of 50 and 100 nM reduced the secretion of IL-6 and
TNF-α, while also inhibiting the expression of cyclooxygenase 2 (COX-2) and iNOS.
More recent studies in our laboratory has shown that fermented rooibos extract shows anti-
inflammatory effect by suppressing lipopolysaccharide-triggered inflammatory response. In
the liver, fermented rooibos consumption suppressed the elevation in pro-inflammatory
cytokines, TNF-α and IL-6 [212], while increasing the plasma level of anti-inflammatory
cytokine, IL-10 [276]. Lee and Bae [277] investigated the anti-inflammatory effects and
underlying mechanisms of aspalathin and nothofagin against LPS-mediated vascular inflam‐
matory responses in HUVECs and mice. Results from this study showed that both compounds
possess anti-inflammatory functions in vitro by inhibiting LPS-induced barrier disruption,
expression of cell adhesion molecules (CAMs) and adhesion/transendothelial migration of
neutrophils to endothelial cells, as well as hyper-permeability and leukocyte migration in
vivo. Furthermore, treatment with each compound ameliorated LPS-induced lethal endotox‐
aemia and suppressed the production of TNF-α, IL-6 and activation of nuclear factor-кβ (NF-
кβ) or extracellular regulated kinases (ERK) 1/2. These studies demonstrated that rooibos and
its major flavonoids may contribute to the reduction of inflammation and be preventive against
related diseases.
9.6. Human studies
Reports examining the health benefits of rooibos in humans have been scarce and limited.
However, various health-promoting effects, including antioxidant and oxidative stress
modulation, inhibition of postprandial oxidative stress, inhibition of angiotensin-converting
enzymes (ACEs), lipid profile modulation, promotion of hair growth and anti-wrinkle activity,
among others, have been reported for rooibos in humans.
The first human study with rooibos was conducted by Hesseling et al. [278], when they studied
the effects of rooibos compared with black tea and water on iron absorption in 30 healthy young
men. The study revealed that rooibos consumption (200 mL for 14 days) did not have a
deleterious effect on the iron status parameters, such as haemoglobin, ferritin, transferrin,
serum iron and iron-binding capacity, compared with the control group taking water. A more
recent parallel intervention study, involving 175 primary school children in South Africa,
revealed that the consumption of 200-mL servings of rooibos twice daily for 16 weeks did not
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have any adverse effects on the iron status parameters including serum ferritin, transferrin,
the total iron-binding capacity and the transferrin saturation [279].
A study to test the potential antihistaminic effects of rooibos was conducted in seven patients
diagnosed with either asthma or hay fever. Ingestion of fermented rooibos or topical applica‐
tion of a rooibos poultice did not produce any anti-allergenic activities [280]. The dermato‐
logical potential of rooibos was demonstrated in a study that revealed the consumption of a
diluted infusion of rooibos at least once a week is beneficial to patients with dermatological
diseases. In this study, rooibos consumption decreased the incidence of recurrent Herpes
simplex and human papilloma virus infection, while patients with atopic dermatitis were
successfully treated, resulting in a decrease in itching sensation. In addition, rooibos con‐
sumption inhibited the infiltration of neutrophils associated with Behcet’s disease, Psoriasis
vulgaris and Acne pustulosa [281]. The anti-wrinkle activity of rooibos was demonstrated in a
recent study, when a commercial extract of a rooibos blend with Camelia sinensis extract was
topically applied to female skin. Results obtained from the study indicated that the extract
reduced skin wrinkles by 10%; however, no effect was shown on skin smoothness, roughness
and scaliness [282]. Also, Glynn [283] demonstrated that a blend of botanical extracts contain‐
ing unfermented rooibos, when topically applied to male, promoted hair growth by increasing
hair density, number of anagen follicles and hair growth rate.
Sauter [284] investigated the effect of an aspalathin-enriched extract of unfermented rooibos
(15% aspalathin) on the plasma antioxidant status of 20 subjects who were given an oral dose
(250 mg/tablet) twice daily for 14 days with diet restrictions to ensure low flavonoid intake
during the study period. Rooibos consumption did not show any effect on the antioxidant
status biomarkers monitored, except a slight decrease in the antioxidant status when the
xanthine/xanthine oxidase assay was used. In another study, the effect of unfermented rooibos
consumption on the antioxidant status of workers who were occupationally exposed to lead
was investigated in a randomized placebo-controlled 8-week intervention trial. The study
monitored the indices of lead exposure (blood lead (PbB), erythrocyte porphyrins (EPs) and
delta-aminolevunilic acid dehydratase (ALAD)) and antioxidant status markers (SOD, GSH
and MDA) in the erythrocytes and plasma. Rooibos consumption did not have any effect on
the mean blood lead and erythrocyte porphyrin levels (lead exposure status), but there was a
modulation of antioxidant status of the lead-exposed workers as shown by the decreased MDA
levels and increased SOD activity and GSH levels in the plasma and erythrocytes of these
factory workers [285]. More recently, a study by Francisco [286] showed that fermented rooibos
consumption modulated postprandial glycaemia, lipaemia and oxidative stress in healthy
subjects after an intake of a standardized fat meal. Consumption of rooibos by the subjects
improved their redox status by increasing the total GSH and significantly lowering the level
of conjugated dienes and TBARS after 6 hours. Further, the levels of total cholesterol, LDL
cholesterol and triacylglycerol as well as high sensitive C-reactive proteins (hs-CRP) were all
decreased in the same study. Guerreiro et al. [287] revealed that the consumption of a rooibos
infusion with added glucose (25 g) did not change the glycaemic response when compared to
the reference solution (water with 25 g of glucose) after 2 hours in a Caucasian population of
young male and female adults aged 17–24 years, showing that rooibos is a healthy beverage
for obese and diabetic patients. An acute, cross-over design intervention study involving 15
healthy volunteers consuming 500 mL of either water or fermented or unfermented rooibos
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showed that the plasma antioxidant capacity using the TRAP assay increased significantly
with both rooibos extracts, reaching a peak 1 hour post consumption. No change in triacyl‐
glycerol, cholesterol or uric acid levels was observed with any of the treatments, while a
transitory increase in glycaemia observed at 30 minutes was linked to a glucose upload [288].
Marnewick et al. [289] showed that the consumption of six cups of fermented rooibos herbal
tea for 6 weeks improved the blood-lipid profile and reduced oxidative stress by decreasing
lipid peroxidation and improving the redox status (GSH:GSSG) of adults at risk of CVDs. This
study provided the first clinical evidence in humans of the ability of rooibos to modulate
oxidative stress in adults at risk for developing heart disease.
A recent randomized, three-phase cross-over study investigated the effect of green tea, black
tea and rooibos on the activity of the angiotensin-converting enzyme (ACE) and nitric oxide
(NO) level in healthy volunteers. Study subjects received a single oral dose of 400 mL green
tea, black tea or rooibos, with the activity of ACE and NO concentration measured at 0, 30, 60
and 180 minutes. The oral intake of a single dose (400 mL) of rooibos significantly inhibited
ACE activity after 30 and 60 minutes, while no significant modulation was seen for green and
black teas. When subjects were divided into subgroups according to ACE genotype, those with
genotype II and ID showed significant inhibition of ACE activity after intake of rooibos.
Rooibos consumption did not have any effect on NO concentration, blood pressure and heart
rate [290]. The results of this study are highly significant, since ACE inhibitors are the first-line
treatment of hypertension and thus common drugs used for cardiovascular diseases, suggest‐
ing that rooibos may have antihypertensive and cardiovascular effects through the inhibition
of ACE activity.
9.7. Adverse reactions and/or toxicity
Although there is no evidence of any toxicological study that have been conducted for rooibos,
however, a number of studies have addressed aspects of safety and toxicity. A widely used
measure of safety of medicinal and plant extracts in literature is to determine their effect on
serum levels of liver and kidney function markers. Increased serum levels of alanine amino‐
transferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and lactate
dehydrogenase (LDH) are used as surrogate markers for hepatic injury. Animal studies from
our laboratory and elsewhere have shown that the consumption of unfermented and ferment‐
ed rooibos as the sole source of drinking fluid over different lengths of time did not cause any
adverse effect regarding body weight, liver weight or liver and kidney parameters including
serum transaminases, alkaline phosphatase, creatinine, total and unconjugated bilirubin, total
protein, total cholesterol or iron status [208,211,212,215,216,247]. Results from the first human
intervention study also demonstrated the first scientific proof for human safety of rooibos
consumption, as none of the participants reported any adverse effect and the clinical pathology
results (ALT, AST, GGT, ALP, LDH, creatinine, bilirubin, glucose and protein) were all within
the reference range [289]. The observations from these studies become all the more important,
especially with recent cases of possible adverse hepatic effects of rooibos. Sinisalo et al. [291]
reported a case of a 42-year-old patient diagnosed with a low-grade B-cell malignancy,
Waldenstrom’s macroglobulinaemia, 6 years earlier, who temporarily experienced elevated
liver enzymes after consuming relatively large amounts of rooibos. The study reaffirms the
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excellent safety record of rooibos and concluded that the contamination of the rooibos herbal
tea by some hepatotoxic compound, genetic predisposition and/or diseased state of the patient
to react adversely to one of the many bioactive components in rooibos may be responsible for
the effect. A very recent study also reported a case of acute hepatitis and liver failure associated
with daily ingestion of rooibos and buchu herbal tea in a 52-year-old man with a history of
hyperlipidaemia and stage III chronic kidney disease secondary to IgA nephropathy [292].
These two reports underlined the fact that further study still needs to be done on the safety of
rooibos consumption in humans despite the excellent safety record of the tea to date, and also
draw attention to the health status of the individual being very important when considering
supplementation with dietary antioxidants.
10. Conclusion and future research directions
The attractiveness and use of naturally occurring compounds including those derived from
fruits, vegetables and herbs as potential chemopreventive and chemotherapeutic agents have
become a fascinating strategy, and from the various studies reviewed here, it is evident that
rooibos and/or its polyphenols hold great potential not only in the prevention but also in
therapy of a wide variety of oxidative stress-induced conditions. Since the first report on the
biological activity of rooibos, an enormous body of work has revealed that rooibos extracts
possess antioxidant, antimutagenic, anti-inflammatory, anti-diabetic, antimicrobial and, above
all, cancer-preventive properties. However, most of the studies have been done in vitro, with
ex vivo, in vivo and human trials still limited. This review strongly advocates a shift in focus
from in vitro studies to animal and human studies, with future research aimed at defining the
actual magnitude of health benefits, establishing a safe range of rooibos tea consumption
associated with these benefits (if toxicity is discovered) and elucidating the mechanisms of
action in order to predict its efficacy. In addition, definitive conclusions concerning the health
benefits of rooibos consumption must come from well-designed observational epidemiological
studies and clinical intervention trials. For rooibos and/or its flavonoids to have beneficial
effects in vivo, they have to be absorbed and metabolized in such a way that they can reach
and target specific sites. Therefore, more studies are needed to focus on rooibos bioavailability,
as well as dose–response effects and pharmacokinetic profiling of the hypothetic active
metabolites. Studies analysing the effect of rooibos extract in order to follow the synergistic
bioactivity of the different flavonoids present in rooibos are also necessary.
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